ZA854745B - Method for improving the absorption and effectiveness of a catecholamine compound - Google Patents

Method for improving the absorption and effectiveness of a catecholamine compound

Info

Publication number
ZA854745B
ZA854745B ZA854745A ZA854745A ZA854745B ZA 854745 B ZA854745 B ZA 854745B ZA 854745 A ZA854745 A ZA 854745A ZA 854745 A ZA854745 A ZA 854745A ZA 854745 B ZA854745 B ZA 854745B
Authority
ZA
South Africa
Prior art keywords
effectiveness
absorption
improving
catecholamine compound
catecholamine
Prior art date
Application number
ZA854745A
Other languages
English (en)
Inventor
Cesare Casagrande
Francesco Santangelo
Original Assignee
Simes
Sint Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simes, Sint Spa filed Critical Simes
Publication of ZA854745B publication Critical patent/ZA854745B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/62Isoquinoline or hydrogenated isoquinoline ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532Seven-(or more) membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA854745A 1984-06-25 1985-06-24 Method for improving the absorption and effectiveness of a catecholamine compound ZA854745B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8421583A IT1213182B (it) 1984-06-25 1984-06-25 Derivati di composti a struttura catecolamminica.

Publications (1)

Publication Number Publication Date
ZA854745B true ZA854745B (en) 1986-03-26

Family

ID=11183927

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA854745A ZA854745B (en) 1984-06-25 1985-06-24 Method for improving the absorption and effectiveness of a catecholamine compound

Country Status (11)

Country Link
US (1) US4673671A (sv)
EP (1) EP0167204B1 (sv)
JP (1) JP2520590B2 (sv)
AT (1) ATE46697T1 (sv)
AU (1) AU578294B2 (sv)
CA (1) CA1260464A (sv)
DE (1) DE3573259D1 (sv)
ES (1) ES8703483A1 (sv)
FI (1) FI83420C (sv)
IT (1) IT1213182B (sv)
ZA (1) ZA854745B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2070994T3 (es) * 1989-04-20 1995-06-16 Zambon Spa Profarmaco de dopamina.
IT1236843B (it) * 1989-11-22 1993-04-21 Simes Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
IT1255471B (it) * 1992-07-30 1995-11-02 Zambon Spa Derivati di catecolammine,processo per la loro preparazione e composizioni farmaceutiche che li contengono
US6030961A (en) * 1997-03-11 2000-02-29 Bar-Ilan Research & Development Co., Ltd. Oxyalkylene phosphate compounds and uses thereof
EP1175425A2 (en) 1999-01-21 2002-01-30 The Board Of Regents, The University Of Texas System Inhibitors of intestinal apical membrane na/phosphate co-transportation
US6787044B1 (en) * 2003-03-10 2004-09-07 Archimedes Technology Group, Inc. High frequency wave heated plasma mass filter
JP4591045B2 (ja) 2004-11-08 2010-12-01 株式会社東京ベル製作所 ベル装置の打撃機構
EP3209302B1 (en) * 2014-10-21 2019-04-24 AbbVie Inc. Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
US20220220077A1 (en) 2019-05-21 2022-07-14 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL96045C (sv) * 1956-05-31
US3132171A (en) * 1962-06-18 1964-05-05 Strong Cobb Arner Inc 3, 4-diphosphatophenyl-alanine and process for making same
US3914343A (en) * 1973-07-20 1975-10-21 Warner Lambert Co Phosphoric acid esters of 5-(2-aminoethoxy)-carvacrols
FR2444043A1 (fr) * 1978-12-15 1980-07-11 Bottu Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique
US4508706A (en) * 1983-03-30 1985-04-02 Yale University Composition for increasing melanin in mammalian skin and hair

Also Published As

Publication number Publication date
EP0167204B1 (en) 1989-09-27
EP0167204A1 (en) 1986-01-08
JP2520590B2 (ja) 1996-07-31
CA1260464A (en) 1989-09-26
AU578294B2 (en) 1988-10-20
AU4412885A (en) 1986-01-02
DE3573259D1 (en) 1989-11-02
FI83420B (fi) 1991-03-28
ES545014A0 (es) 1987-03-01
JPS6183193A (ja) 1986-04-26
ATE46697T1 (de) 1989-10-15
FI852510A0 (fi) 1985-06-25
IT1213182B (it) 1989-12-14
ES8703483A1 (es) 1987-03-01
US4673671A (en) 1987-06-16
FI83420C (sv) 1991-07-10
FI852510L (fi) 1985-12-26
IT8421583A0 (it) 1984-06-25

Similar Documents

Publication Publication Date Title
PT81000B (pt) Processo para a preparacao de compostos de fenilpiridina substituidos
GB2156844B (en) Process for the isomerization of butenes
GB2103647B (en) Process for the preparation of organic compounds
DE3573259D1 (en) Method for improving the absorption and effectiveness of a catecholamine compound
BR8206388A (pt) Processo para a preparacao de compostos
AU559542B2 (en) A process to increase the effectiveness of bagasse as a source of energy
GB8503039D0 (en) Ultra-violet absorbing compounds
DE3274975D1 (en) Process for ammoxidation of organic compounds
DE3062846D1 (en) Improved process for producing phenolic compounds from aralkyl hydroperoxides
DE2964157D1 (en) A process for the dimerisation of acrylonitrile
JPS5657788A (en) Acetoxymethylpenam compound as betaalactamase inhibitor
BR8500014A (pt) Processo para a estabilizacao de poliolefinas
BR8103889A (pt) Processo para a preparacao de compostos
DE3261853D1 (en) Process for the ortho-methylation of phenolic compounds
GB2050851B (en) Method for the recovery of acetone
AU587375B2 (en) Process for treating uraniferous solutions by the addition of a aluminum salt
BR8101594A (pt) Processo para a preparacao de compostos de dihalogenotriazinil-amino-naftol
CU35227A (en) Method to produce chemicals compounds
JPS5675424A (en) Psoriasis treating method and composition by retinoyl compounds
BR8401391A (pt) Processo para a preparacao de um composto de amino-nitrila
IE840280L (en) Anthracycline compound
PT80220B (en) Process for the preparation of by-products of 1-phenylindole u seful as anti-diarrheal
UA7039A1 (uk) Спосіб боротьби з небажаною рослинністю
GR81773B (sv)
HUT35232A (en) Process for production of 1-substituated-2,2-dichloreaevinile compound with reductive elimination